These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 6347400

  • 41. [Immunologic disorders in patients with an active form of pulmonary sarcoidosis].
    Wolska-Goszka L.
    Wiad Lek; 1984 May 15; 37(10):777-81. PubMed ID: 6390975
    [No Abstract] [Full Text] [Related]

  • 42. Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells.
    Center DM, Cruikshank W.
    J Immunol; 1982 Jun 15; 128(6):2563-8. PubMed ID: 7042840
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Leukocyte migration in guinea pigs. II. Partial characterization of a leukocyte migration inhibitory factor distinct from macrophage migration inhibitory factor.
    Hoffman PM, Hanes DM, Horsmanheimo M, Fudenberg HH.
    Cell Immunol; 1977 Apr 15; 30(1):92-9. PubMed ID: 324645
    [No Abstract] [Full Text] [Related]

  • 45. The effect of a factor from multiple sclerosis serum on isolated T and B lymphocytes.
    Armentrout SA, Sweet PM, Galant SP.
    J Clin Lab Immunol; 1981 May 15; 5(3):133-6. PubMed ID: 6972451
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Production of human lymphocyte mediators after activation with periodate or neuraminidase and galactose oxidase.
    Greineder DK, Rocklin RE, David JR.
    J Immunol; 1979 Dec 15; 123(6):2804-7. PubMed ID: 227960
    [Abstract] [Full Text] [Related]

  • 48. Production of leukocyte migration inhibition factor (LIF) and migration stimulation factor (MStF) by CD4+ and CD8+ human lymphocytes subsets and T-cell clones.
    Méndez-Samperio P, Jiménez-Zamudio L, Favila-Castillo L.
    Rev Invest Clin; 1989 Dec 15; 41(2):107-15. PubMed ID: 2675234
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Disparity of mixed lymphocyte reactivity to cultured cells of human T and B lymphoid lines.
    Pauly JL, Minowada J, Han T, Moore GE.
    J Natl Cancer Inst; 1975 Mar 15; 54(3):557-62. PubMed ID: 123598
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Mechanism of synergy between T cell signals and C8-substituted guanine nucleosides in humoral immunity: B lymphotropic cytokines induce responsiveness to 8-mercaptoguanosine.
    Goodman MG.
    J Immunol; 1986 May 01; 136(9):3335-40. PubMed ID: 3514757
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Characterization of the lymphokine responsible for migration-inhibitory activity against tumor cells.
    Cohen MC.
    Cancer Res; 1982 Jun 01; 42(6):2135-8. PubMed ID: 6978764
    [Abstract] [Full Text] [Related]

  • 59. Eosinophils and immune mechanisms. II. Partial characterization of the lymphokine eosinophil stimulation promoter.
    Greene BM, Colley DG.
    J Immunol; 1974 Sep 01; 113(3):910-7. PubMed ID: 4606520
    [No Abstract] [Full Text] [Related]

  • 60. Cellular and growth factor requirements for activation of human T lymphocytes by neuraminidase and galactose oxidase-treated lymphoid cells.
    Lipkowitz S, Rubin AL, Stenzel KH, Novogrodsky A.
    J Immunol; 1983 Jun 01; 130(6):2702-7. PubMed ID: 6602177
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.